Regenerative Medicine
Advanced treatment modalities used by Dr. Pavelescu — including therapeutic peptides, platelet rich plasma (PRP), joint viscosupplementation, and fat pad restoration using human fat tissue allograft — to harness the body's own healing mechanisms to repair, restore, or replace damaged tissue
OVERVIEW
What Is Regenerative Medicine?
Regenerative medicine has changed how doctors treat foot and ankle pain. The lower extremities suffer from poor blood circulation, immense daily pressure, and high wear and tear, which makes injuries notoriously slow to heal. Traditionally, if standard treatments like resting, ice, or custom orthotics failed, patients were left with few options: get a cortisone shot (which temporarily masks the pain but can weaken tissue over time) or undergo invasive surgery. Regenerative podiatry provides a middle ground. Instead of masking symptoms or cutting into the foot, Dr. Pavelescu use biological materials to repair damaged tendons, ligaments, cartilage, and even stubborn wounds from the inside out.
Regenerative medicine in foot and ankle surgery aims to harness the body's own healing mechanisms to repair, restore, or replace damaged tissue rather than simply relieving symptoms or removing the problem surgically. Among the most established biologic options is platelet-rich plasma (PRP), an autologous concentrate of platelets drawn from the patient's own blood and delivered by image-guided injection. PRP releases growth factors such as PDGF, TGF-β, and VEGF that modulate inflammation and promote tissue remodeling. It is most commonly used for chronic plantar fasciitis, Achilles and peroneal tendinopathy, ankle sprains, and early osteochondral lesions of the talus. It is also used as an adjunct during surgical repair. Evidence is strongest for plantar fasciitis and tendinopathy, though results vary with platelet concentration, leukocyte content, and injection technique.
Peptide-based therapies are an emerging area. Agents such as BPC-157 and thymosin beta-4 have shown promise in preclinical studies for tendon, ligament, and soft tissue healing through angiogenesis and cell migration. Human clinical data for these agents remain limited, and many are not FDA-approved for musculoskeletal use, so they are best considered investigational and used within regulated, evidence-informed frameworks.
Fat pad restoration addresses the atrophy of the heel and forefoot padding that causes chronic pain, particularly in older adults, in patients with prior steroid injections, and in those with metatarsalgia. Options include autologous fat grafting, sometimes enriched with adipose-derived stem cells or PRP, as well as injectable fillers. These approaches restore cushioning and shock absorption, often providing lasting relief when orthotics and padding have failed.
Together, these modalities offer minimally invasive alternatives or complements to surgery, with the potential for faster recovery and fewer complications. Rigorous patient selection, realistic expectations, and continued clinical research remain essential as the field evolves.
Peptide Therapy
The landscape of surgical recovery is undergoing a transformation that extends far beyond traditional post-operative care. While surgeons have perfected minimally invasive techniques and enhanced recovery protocols, a new frontier in healing optimization is emerging through the strategic use of therapeutic peptides. These powerful molecular messengers are demonstrating remarkable abilities to accelerate wound healing, reduce complications, and optimize the biological processes that determine surgical success.
Peptides are small, naturally occurring molecules made up of short chains of amino acids that function as your body's highly specific natural communication system. Peptides carry specific instructions between your body’s cells about healing, repair, and regeneration. When surgery creates tissue trauma, your body initiates complex healing cascades involving inflammation, cellular migration, protein synthesis, and tissue remodeling. Therapeutic peptides can enhance and optimize each of these processes. As a result, these have become an increasingly important tool in regenerative and reconstructive medicine due to their ability to modulate inflammation, angiogenesis, and cellular repair pathways with a precision that broader pharmacologic agents often lack. In recent years, doctors have found new ways to use peptides to support healing, from special gels that help stubborn wounds close to treatments that help bones heal after a fracture or reconstructive surgery.
The key advantage of peptide therapy lies in its ability to work with your body's existing healing mechanisms rather than overriding them with synthetic interventions. This approach produces more natural, sustainable healing while minimizing the side effects often associated with traditional post-operative medications. Modern surgical recovery protocols increasingly recognize that the quality and speed of healing depend not just on surgical technique, but also on providing the cellular environment and molecular signals necessary for optimal tissue repair. Peptide therapy addresses this need by delivering precise biological instructions that enhance every aspect of the healing process. In the postoperative setting specifically, peptide-based therapies offer several potential benefits for foot and ankle surgery patients: they may accelerate soft tissue and osseous healing, reduce the incidence of delayed union or wound dehiscence, support angiogenesis in poorly vascularized surgical beds, and potentially shorten overall recovery timelines—outcomes particularly valuable in higher-risk populations such as diabetic or vasculopathic patients undergoing elective or reconstructive procedures.
Dr. Pavelescu’s approach to peptide-enhanced surgical recovery involves a comprehensive assessment of each patient's healing potential and optimization needs. Pre-operative evaluation identifies factors that might impair healing, such as poor nutrition, compromised immune function, or age-related hormone decline. This assessment guides the selection and timing of peptide interventions for optimal individual outcomes. Post-operative peptide protocols are carefully coordinated with traditional recovery measures to enhance rather than complicate the healing process. Regular monitoring ensures that peptide therapy produces expected benefits and allows for protocol adjustments based on healing progress and individual response patterns. The integration of peptide therapy with advanced surgical techniques creates a comprehensive care model that addresses both the structural and biological aspects of surgical recovery. This approach often produces healing outcomes that exceed what traditional post-operative care alone can achieve.
Peptide-enhanced surgical recovery represents the evolution of surgical medicine from simply performing procedures to optimizing the entire healing process. As our understanding of peptide mechanisms continues to advance, even more sophisticated approaches to surgical recovery enhancement will emerge. Patients who embrace this integrative approach to surgical care position themselves to benefit from the most advanced healing optimization available. The combination of surgical expertise with biological enhancement creates opportunities for faster recovery, better outcomes, and improved long-term results that traditional approaches cannot match.
Musculoskeletal PRP
Platelet-rich plasma (PRP) is an autologous blood product. Whole blood is centrifuged to concentrate platelets, which release growth factors (PDGF, TGF-β, VEGF, IGF-1 and others) when activated. The theory is that this can push a stalled, degenerative tissue back toward a repair response. That is why PRP is aimed at chronic tendon and fascia problems, which are now understood as degenerative tendinopathy rather than true inflammation, and not at acute injuries.
In Dr. Pavelescu’s practice, this treatment modality is used as a middle option. It sits between failed conservative care (stretching, orthoses, load management, NSAIDs, shockwave) and surgery. Corticosteroid injection is the usual comparator, and it carries risks of fat pad atrophy, fascial rupture and tendon weakening.
Practical variables that affect results
Leukocyte content. Leukocyte-poor PRP is often preferred for tendon work, since leukocyte-rich preparations may aggravate inflammation. This is a common but not universal view, and the evidence is still developing.
Preparation and dosing. Spin protocols, platelet concentration, activation method, volume, and the number and spacing of injections all vary between studies.
Guidance. Ultrasound-guided injection is generally favored for precise placement, particularly in tendons.
Peri-procedure factors. Typical practice is to avoid NSAIDs before and after injection, and to follow with a graded loading or rehabilitation program. These are common clinical conventions rather than points proven in the trials I reviewed.
Costs. PRP is usually self-pay, and insurers often classify it as investigational, eventhough there is a plethora of research backing its use.
For plantar fasciitis (heel and arch pain): This is where PRP has the best research behind it. Studies suggest it can reduce pain and improve how your foot works. Compared with a steroid injection, steroids tend to relieve pain faster, while PRP may give better relief at about 3 to 6 months. It also avoids some steroid risks, such as thinning of the heel's fat pad. By one year, the difference between the two is less clear.
For Achilles tendon pain: The research is mixed, and several of the better-designed studies did not find clear extra benefit over placebo or exercise alone. PRP may help some people, but we can't promise it will. Your strengthening and stretching program remains the most important part of treatment, and PRP would be an add-on to it.
What to keep in mind:
Improvement is usually gradual, over weeks to months, not immediate.
Some soreness after the injection is common.
Serious complications are rare, since the PRP comes from your own blood.
It doesn't work for everyone and isn't a guaranteed cure.
Insurance often doesn't cover it, so ask about cost beforehand.
PRP can be a reasonable next step for stubborn heel pain, or tendinopathy that has not responded adequately to conservative care, especially if you want to avoid repeated steroid injections.
Safety and contraindications
PRP is autologous, so serious adverse events are uncommon. The usual issues are post-injection pain flare, infection (rare), and bleeding. Typical contraindications include platelet disorders, active infection at the site, anticoagulation concerns, and active malignancy. Confirm the specifics against current protocols
Fat Pad Restoration
The foot has specialized cushioning: the heel pad and the plantar forefoot (submetatarsal) fat pads. These are dense fibrous-septated fat chambers that absorb impact and spread load during walking. When this tissue thins, shifts, or is lost, bone and skin take on forces they weren't built for. Fat pad restoration (also called fat pad augmentation) is a group of procedures that replace or rebuild this cushioning. It sits at the border of podiatry, foot and ankle surgery, and reconstructive plastic surgery, and it is considered regenerative because several approaches use living or biologically active tissue rather than inert padding.
Causes of fat pad atrophy
Plantar fat pad atrophy may be age-related, or due to abnormal foot mechanics, steroid use, or collagen vascular disease. Other contributors include prior foot surgery, failed neuroma surgery, and overuse, as seen in one randomized trial population. Steroid injections can also cause or worsen existing heel fat pad atrophy. In diabetes, neuropathy, altered gait, and structural deformities such as claw toes and prominent metatarsal heads add to the problem. Fat pad displacement is a related issue: loss or displacement of a fat pad increases plantar pressure, leading to pain and plantar ulcers.
Benefits for pain
The mechanism is mechanical. Plantar pressure correlates directly with plantar tissue thickness, and loss of plantar fat is a fundamental mechanism of pressure-related foot disorders. Restoring volume lowers peak pressures and gives the metatarsal heads or calcaneus a cushion again.
Metatarsalgia and pain under the metatarsal heads
Heel pain from heel pad atrophy, which is the second most common cause of heel pain
Pain after steroid injections, foot surgery, or neuroma procedures
Painful calluses and corns from focal pressure
Preventing complications in vulnerable patients
In the diabetic neuropathic foot, loss of protective sensation means high pressure goes unnoticed until the skin breaks down. Fat pad restoration is being explored as a preventive and recurrence-reduction tool in several settings:
Pre-ulcerative lesions. Candidates may include diabetic neuropathic patients with pre-ulcerative lesions, a history of plantar ulcers, or newly closed ulcers, as well as post-traumatic and post-surgical patients with adipose deficiency.
Ulcers in remission. The goal is to reduce re-ulceration, which is common. Fat grafting has been described alongside tendon balancing in a patient with a diabetic ulcer in remission.
Patients unsuitable for major surgery. Some patients are not medically stable enough for aggressive osseous surgery, and transfer lesions and re-ulceration are common after ulcer surgery. A minimally invasive soft-tissue approach may be an alternative or adjunct.
Downstream outcomes. The theoretical chain is lower pressure, fewer ulcers, and fewer cases of osteomyelitis and amputation. Heel pad augmentation may reduce ulcer formation or reformation and the subsequent comorbidities of osteomyelitis and amputation. This chain is plausible but not yet proven in large trials.
Treatment approaches
Autologous fat grafting (lipofilling). Fat is harvested from another site, typically abdomen or flank, and injected into the bottom of the foot. In a published case, about 25 mL was harvested from the anterior abdomen and injected through multiple stab incisions beneath the first metatarsal head and fifth metatarsal base, followed by a period of non-weight-bearing. Early experience was limited by fat necrosis, but more recent research has documented effectiveness for both pedal and heel fat pad atrophy.
Adipose tissue allografts. These are processed donor adipose products that avoid a harvest procedure. One pilot study gave a human adipose allograft to 12 patients with diabetic neuropathy and reported no ulcer formation, recurrence, or adverse events. Some clinics now market branded injectable products of this type for fat pad restoration.
Fillers and other options. Silicone injections, hyaluronic acid or other dermal fillers, and other temporary fillers have been used. Current modalities include silicone injections, fat injections, and other temporary fillers. Fillers offer short-term cushioning and are less likely to integrate biologically. Orthobiologic adjuncts such as adipose-derived stem cells and PRP are being investigated, including research on adipose stem cell characteristics and how they correlate with fat retention.
Joint Viscosupplementation Therapy
Viscosupplementation is the injection of hyaluronic acid (HA) into a joint to supplement the viscoelastic properties of synovial fluid. HA is a naturally occurring glycosaminoglycan that gives synovial fluid its lubricating (viscous) and shock-absorbing (elastic) qualities. In osteoarthritis (OA), both the concentration and molecular weight of native HA fall, reducing lubrication and cartilage protection.
Viscosupplementation is a low-risk, minimally invasive, off-label option for mild to moderate foot & ankle joint OA. Dr. Pavelescu will assess and discuss if this is an appropriate treatment for your particular condition and weigh it against alternatives based on the stage of disease and your particular goals.
Proposed Mechanisms
Mechanical: restores lubrication and cushioning of the joint
Biological: reduces inflammatory mediators (e.g., IL-1β, prostaglandins, MMPs), stimulates endogenous HA production, and supports chondrocyte (cartilage cell) function
Analgesic: may modulate nociceptors (pain receptors) in the joint capsule and synovium
The effect often outlasts the residence time of the injected HA (which is only days to weeks), suggesting biological effects beyond simple fluid replacement.
Common Targets
Ankle (tibiotalar) OA
First metatarsophalangeal joint (hallux rigidus)
Subtalar and midfoot joints
Typical Candidates
Patients with mild to moderate OA
Patients who have failed conservative care (NSAIDs, bracing, orthotics, activity modification, physical therapy)
Patients who want to delay or avoid surgery (arthrodesis, arthroplasty, cheilectomy)
Patients who are poor surgical candidates